Chundong Gu

Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 <i>EGFR</i>-Mutant Non–Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study

Wen‐Zhao Zhong, Ke‐Neng Chen, Chun Chen et al. · Journal of Clinical Oncology · 2019 · 267 citations

Medicine, Oncology, Pharmacology +15

SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance

Junxiu Sheng, Qingzhi Zhao, Jinyao Zhao et al. · EBioMedicine · 2018 · 168 citations · Full text

Life Sciences, Molecular Biology, Oncology +16

Prognostic Impact of Micrometastatic Tumor Cells in the Lymph Nodes and Bone Marrow of Patients With Completely Resected Stage I Non–Small-Cell Lung Cancer

Toshihiro Osaki, Tsunehiro Oyama, Chundong Gu et al. · Journal of Clinical Oncology · 2002 · 137 citations

Medicine, Oncology, Pathology +13

Detection of Micrometastatic Tumor Cells in pN0 Lymph Nodes of Patients With Completely Resected Nonsmall Cell Lung Cancer

Chundong Gu, Toshihiro Osaki, Tsunehiro Oyama et al. · Annals of Surgery · 2002 · 135 citations · Full text

Medicine, Oncology, Pathology +17

Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence

Hidehiko Shimokawa, Hidetaka Uramoto, Takamitsu Onitsuka et al. · Journal of Thoracic and Cardiovascular Surgery · 2010 · 94 citations · Full text

Medicine, Molecular Biology, Oncology +14